HCV Guidance
Published on HCV Guidance (https://www.hcvguidelines.org)

Home > Home > Contents

Welcome and Methods

  • Introduction
  • Methods
  • Table 1. Summary of the Process and Methods for the Guidance Development
  • Table 2. Rating System Used to Rate Level of Evidence and Strength of Recommendation
  • Table 3. Commonly Used Abbreviations

Test, Evaluate, Monitor

  • Testing, Evaluation, and Monitoring of Hepatitis C
  • HCV Testing and Linkage to Care
  • When and in Whom to Initiate HCV Therapy
  • Overview of Cost, Reimbursement, and Cost-Effectiveness Considerations for Hepatitis C Treatment Regimens
  • Monitoring Patients Who Are Starting HCV Treatment, Are on Treatment, or Have Completed Therapy
  • HCV Resistance Primer

Treatment-Naive

  • Initial Treatment of Adults with HCV Infection
  • Simplified HCV Treatment* for Treatment-Naive Adults Without Cirrhosis
  • Simplified HCV Treatment Algorithm for Treatment-Naive Adults With Compensated Cirrhosis
  • Treatment-Naive Genotype 1
  • Treatment-Naive Genotype 1a Without Cirrhosis
  • Treatment-Naive Genotype 1a With Compensated Cirrhosis
  • Treatment-Naive Genotype 1b Without Cirrhosis
  • Treatment-Naive Genotype 1b With Compensated Cirrhosis
  • Treatment-Naive Genotype 2
  • Treatment-Naive Genotype 2 Without Cirrhosis
  • Treatment-Naive Genotype 2 With Compensated Cirrhosis
  • Treatment-Naive Genotype 3
  • Treatment-Naive Genotype 3 Without Cirrhosis
  • Treatment-Naive Genotype 3 With Compensated Cirrhosis
  • Treatment-Naive Genotype 4
  • Treatment-Naive Genotype 4 Without Cirrhosis
  • Treatment-Naive Genotype 4 With Compensated Cirrhosis
  • Treatment-Naive Genotype 5 or 6

Treatment-Experienced

  • Retreatment of Persons in Whom Prior Therapy Failed
  • Sofosbuvir-Based and Elbasvir/Grazoprevir Treatment Failures
  • Glecaprevir/Pibrentasvir Treatment Failures
  • Multiple DAA Treatment Failures (All Genotypes), Including Sofosbuvir/Velpatasvir/Voxilaprevir or Sofosbuvir Plus Glecaprevir/Pibrentasvir

Unique Populations

  • Management of Unique & Key Populations With HCV Infection
  • Patients With HIV/HCV Coinfection
  • Patients With Decompensated Cirrhosis
  • Patients Who Develop Recurrent HCV Infection Post Liver Transplantation
  • Treatment of HCV-Uninfected Transplant Recipients Receiving Organs From HCV-Viremic Donors
  • Patients with Renal Impairment
  • Kidney Transplant Patients
  • Management of Acute HCV Infection
  • HCV in Pregnancy
  • HCV in Children
  • Management of Key Populations With Chronic HCV Infection
  • Key Populations: Identification and Management of HCV in People Who Inject Drugs
  • HCV in Key Populations: Men Who Have Sex With Men
  • HCV Testing and Treatment in Correctional Settings

References

  • Reference list sorted by first author


HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C | © 2014-2022 AASLD and IDSA v2022.1